Loading clinical trials...

Pharmacokinetic Study of AEB071 in Patients Following Liver Transplantation | Clinical Trials | Clareo Health

COMPLETEDPhase 1NCT00545259

Pharmacokinetic Study of AEB071 in Patients Following Liver Transplantation

The study will evaluate the pharmacokinetic profile of AEB071 in the immediate post-transplant period in patients who have undergone their first liver transplant.

Lead sponsor: Novartis•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment13

Start dateOct 2007

Last updatedDec 8, 2020

Condition

de Novo Liver Transplantation

Locations shown

Novartis investigative site

Berlin

Novartis Investigative Site

Padova

Novartis investigative site

Zurich

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 8, 2020Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions